George Hill Analyst PerformanceManaging Director, Equity Research Analyst at Deutsche Bank AktiengesellschaftGeorge Hill is a stock analyst at Deutsche Bank Aktiengesellschaft focused in the healthcare sector, covering 20 publicly traded companies. Over the past year, George Hill has issued 22 stock ratings, including buy and hold recommendations. While full access to George Hill's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights George Hill's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings107 Last 11 YearsBuy Recommendations54.81% 57 Buy RatingsCompanies Covered20 Unique Companies Ratings Distribution104RatingsDistribution of strong buy, buy, hold, and sell ratings by George Hill.RatingPercentageCount Strong Buy0.0%0 ratings Buy54.8%57 ratings Hold45.2%47 ratings Sell0.0%0 ratingsOut of 104 total stock ratings issued by George Hill at Deutsche Bank Aktiengesellschaft, the majority (54.8%) have been Buy recommendations, followed by 45.2% Hold.Best & Worst CallsBest Call000.0%EHTHApr 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EHTHFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE70.0% of companies on NYSE14 companiesNASDAQ25.0% of companies on NASDAQ5 companiesOTCMKTS5.0% of companies on OTCMKTS1 companyGeorge Hill, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 20 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare18 companies90.0%Finance1 company5.0%Miscellaneous1 company5.0%George Hill of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Healthcare sector, with additional focus on Finance and companies.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES12 companies60.0%HEALTHCARE TECHNOLOGY4 companies20.0%LIFE SCIENCES TOOLS & SERVICES2 companies10.0%INSURANCE1 company5.0%Miscellaneous1 company5.0% About George HillGeorge Hill joined Deutsche Bank as a Managing Director and equity research analyst covering the Healthcare Technology & Service sector in April 2019. He's been covering the healthcare technology and pharmaceutical services space for over 20 years. Mr. Hill frequently appears in the media, as a regular speaker at industry events, and lectured at the Wharton School on healthcare technology topics. He was Managing Director and senior equity research analyst at RBC Capital Markets, covering the drug supply chain and healthcare technology industries. Prior to RBC, he held similar positions at Deutsche Bank, Citigroup and SVB Leerink. He spent time as the senior calling officer for Leerink's healthcare services investment banking group. Mr. Hill started his career in investment research as an investment associate at Citigroup Asset Management. Before that, he was a journalist covering the pharmaceutical marketing and services space. Mr. Hill holds a bachelor's degree from Rutgers University.Follow on LinkedIn George Hill's Ratings History at Deutsche Bank Aktiengesellschaft Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsHIMSHims & Hers Health8/11/2026Boost Price Target$30.60$26.00Hold$0.0000.00% ROIWAYWaystar7/31/2026Reiterated Rating$21.82$39.00Buy$0.0000.00% ROIHUMHumana7/30/2026Initiated Coverage$367.67Hold$0.0000.00% ROIHUMHumana5/20/2026Downgrade$308.78Hold$0.0000.00% ROICICigna Group5/20/2026Downgrade$291.37$302.00Hold$0.0000.00% ROIHUMHumana5/20/2026Upgrade$309.85$441.00Buy$0.0000.00% ROICNCCentene5/20/2026Upgrade$59.17$80.00Buy$0.0000.00% ROIELVElevance Health5/20/2026Upgrade$402.32$498.00Buy$0.0000.00% ROIAGLAgilon Health5/7/2026Upgrade$27.81$49.00Buy$0.0000.00% ROIAGLAgilon Health4/9/2026Set Price Target$20.39$33.00Hold$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. HQYHealthEquity3/19/2026Boost Price Target$81.60$128.00Buy$0.0000.00% ROIWAYWaystar3/12/2026Lower Price Target$24.50$37.00Buy$0.0000.00% ROIHIMSHims & Hers Health3/10/2026Boost Price Target$22.12$28.00Hold$0.0000.00% ROITDOCTeladoc Health3/10/2026Upgrade$5.31$11.00Buy$0.0000.00% ROIHUMHumana2/13/2026Set Price Target$181.41$180.00Hold$0.0000.00% ROIHIMSHims & Hers Health2/10/2026Set Price Target$18.31$31.00Hold$0.0000.00% ROICICigna Group2/10/2026Boost Price Target$293.06$304.00Buy$0.0000.00% ROIELVElevance Health1/29/2026Reiterated Rating$344.46$332.00Hold$0.0000.00% ROIELVElevance Health12/19/2025Reiterated Rating$344.81$320.00Hold$0.0000.00% ROIMCKMcKesson12/10/2025Reiterated Rating$800.73Buy$0.0000.00% ROICICigna Group11/3/2025Lower Price Target$264.54$301.00Buy$0.0000.00% ROIMCKMcKesson9/24/2025Boost Price Target$739.48$856.00Buy$0.0000.00% ROIGDRXGoodRx8/11/2025Reiterated Rating$3.47$6.00Hold$0.0000.00% ROICICigna Group8/5/2025Set Price Target$271.17$415.00Buy$000.0000.00% ROIHQYHealthEquity6/5/2025Boost Price Target$114.87$115.00Buy$00.0000.00% ROIUNHUnitedHealth Group5/14/2025Lower Price Target$311.69$362.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
